April 18th Gapping up/ down

Gapping up on strong earnings/guidance: LLTC +9.3% (up in sympathy MXIM +5.5%, ADI +2.1%), ASML +4.3%, WM +2.8%... M&A: OMM +4.6% (to be acquired by TK and TRMD for $29.25/share)... Small-cap biotech rally continues on newsflow: AVNR +74.0% (announces positive results of Phase III study for Zenvia in diabetic neuropathic pain), INGN +20.2% (intravenous nanoparticle gene therapy shows activity in stage IV lung cancer patients), CPHD +11.9% (Xpert MRSA test for methicillin-resistant staphylococcus aureus receives FDA clearance), ANX +4.7% (announces positive data from multidrug therapy with CoFactor)... Other news: DPZ +6.2% (completes recapitalization plan, declares $13.50/share special dividend), CTICD +3.4% (settles Qui Tam suit with govt, suit against Medicare reimbursement advisor to recover damages filed), INSW 3.3 (follow-through momentum after yesterday's post-earnings 118% move), ASX +3.2% (broker note says ASX valuation still cheap after Carlyle called off bid).